04:29 PM EDT, 09/27/2024 (MT Newswires) -- James Healy, Director, on September 25, 2024, executed a purchase for 666,665 shares in Bioage Labs ( BIOA ) for $11,999,970. Following the Form 4 filing with the SEC, Healy has control over a total of 26,497 shares of the company, with 26,497 controlled indirectly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1709941/000141588924024044/xslF345X05/form4-09272024_080939.xml

Price: 21.06, Change: +0.06, Percent Change: +0.29